Deepull
PrivateLast Round
Series C
Apr 29, 2025
Total Funding Raised
$102.8M
Company Overview
Deepull operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Series C round in April 2025.
Deepull is a medical diagnostics company developing a culture-free diagnostic system for the rapid, direct-from-blood detection of pathogens and antibiotic resistance associated with sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deepull Comparables
Compare Deepull with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novus Diagnostics | 82% | |
| HelixBind | 82% | |
| Vivid Dx | 80% |
For institutional investors. Book with your work email.
Deepull Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 29, 2025 | ||||
| Series B Extension | Mar 1, 2023 | ||||
| Debt | Dec 5, 2022 | ||||
| Series B | Oct 20, 2022 | ||||
| Series A | Jul 7, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Deepull Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series C, Series B, Series B Extension |
| AXIS Participaciones Empresariales | Series C, Series A, Series B |
| Alta Life Sciences | Series B Extension, Series B, Series A |
| We Venture Capital | Series C |
| CG Health Ventures | Series C |
| Axis Participaciones Empresariales | Series B Extension, Series A, Series B |
| UI Investissement | Series C, Series B Extension, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2025
$57M round closed.
- Dec 5, 2022
$21M round led by European Investment Bank Group.
For institutional investors. Book with your work email.
Deepull Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deepull's valuation, stock price, and market status.
Is Deepull a public or private company?
Deepull is a private company.
What is the current stock price of Deepull?
Deepull is a private company, so its shares have no public market price. Caplight tracks Deepull's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deepull worth (valuation)?
Valuation information for Deepull is not publicly available.
Can I buy Deepull stock?
Deepull shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deepull's last funding round?
Deepull's most recent funding round was Series C on April 29, 2025.
Who are the main investors in Deepull?
Key investors in Deepull include Asabys Partners, Alta Life Sciences, European Investment Bank Group, Panakès Partners, Center for Technological Development and Innovation.
Will Deepull IPO soon?
No public IPO plans have been announced for Deepull.
How can I track Deepull secondary market activity?
Caplight tracks bids, offers, and trades in Deepull's shares on secondary markets.